We are excited to announce that LIFE BioCEEd Medical Investments will be attending BioVaria 2026, taking place on 27–28 April in Munich, Germany.

BioVaria is one of Europe’s leading life sciences events, bringing together top innovators, startups, and investors. It offers a unique platform to showcase breakthrough technologies, explore early-stage opportunities, and build meaningful partnerships across the biotech and pharma ecosystem.

We are looking forward to connecting with inspiring innovators, discovering new technologies, and exploring potential collaborations.

Representing LIFE BioCEEd at the event will be Katarína Orsághová, Ph.D. Katarína holds a PhD from Charles University in collaboration with IOCB Prague. Her research focused on proteolytic enzymes and contributed to the development of novel inhibitors. She combines expertise in biochemistry, molecular biology, and crystallography with a strong interest in translating scientific discoveries into real-world biomedical applications.

At LIFE BioCEEd, she focuses on evaluating innovative biotech ventures in proteomics, enzyme engineering, and molecular medicine, helping identify projects with strong scientific and clinical potential.

If you will be there, feel free to reach out. Katarína Orsághová, Ph. D.

We look forward to meeting you in Munich!